STOCK TITAN

Optimizerx Corp reported $109.4M in revenue and $5.1M in net income for fiscal 2025. See the full OPRX financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

OptimizeRx to Participate in Upcoming Investor Conferences

OptimizeRx Corp (Nasdaq: OPRX), a healthcare technology solutions provider, has announced its participation in two upcoming investor conferences in New York City.

(Neutral)
(Neutral)
Tags
conferences

OptimizeRx Corp (Nasdaq: OPRX), a healthcare technology solutions provider, has announced its participation in two upcoming investor conferences in New York City. The company will attend the 13th Annual ROTH Technology Conference from November 19th-20th, 2024, at The Hard Rock Hotel, and Canaccord Genuity's 2024 CG MedTech, Diagnostics and Digital Health & Services Forum on November 21st, 2024, at The Westin NY Grand Central. Both events will feature one-on-one meeting formats with management.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – OPRX

+9.80%
+9.80% Session move

In the trading session that priced this news, OPRX gained 9.80%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

WALTHAM, Mass., Nov. 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences: 

  • 13th Annual ROTH Technology Conference, New York City, November 19th – 20th, 2024
  • Canaccord Genuity’s 2024 CG MedTech, Diagnostics and Digital Health & Services Forum, New York City, November 21st, 2024

Conference Details: 

13th Annual ROTH Technology Conference
Date: Tuesday, November 19th – Wednesday 20th
Format:1x1 Meetings
Location:The Hard Rock Hotel, New York City

Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
Date: Thursday, November 21st
Format:1x1 Meetings
Location:The Westin NY Grand Central, New York City


To request a meeting or for more details about the conferences please reach out to your institutional contact or email.

About OptimizeRx 
OptimizeRx provides best-in-class health technology that enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting over 2 million U.S. healthcare providers and millions of their patients through an intelligent technology platform embedded within a proprietary digital point-of-care network, as well as mass digital communication channels, OptimizeRx helps life sciences organizations engage and support their customers.

For more information, follow the Company on X, LinkedIn or visit www.optimizerx.com.  

OptimizeRx Contact  
Andy D’Silva, SVP Corporate Finance 
adsilva@optimizerx.com 

Investor Relations Contact 
Ashley Robinson 
LifeSci Advisors, LLC 
arr@lifesciadvisors.com 


FAQ

Which investor conferences will OptimizeRx (OPRX) attend in November 2024?

OptimizeRx will attend the 13th Annual ROTH Technology Conference (Nov 19-20) and Canaccord Genuity's 2024 CG MedTech, Diagnostics and Digital Health & Services Forum (Nov 21) in New York City.

Where will the ROTH Technology Conference featuring OptimizeRx (OPRX) be held in 2024?

The 13th Annual ROTH Technology Conference will be held at The Hard Rock Hotel in New York City.

What is the format of OptimizeRx's (OPRX) participation in the November 2024 conferences?

OptimizeRx will participate in one-on-one meetings format at both conferences.

When and where is the Canaccord Genuity Forum featuring OptimizeRx (OPRX)?

The Canaccord Genuity Forum will be held on Thursday, November 21st, 2024, at The Westin NY Grand Central in New York City.